Laura Navalta

Laura Navalta's Title

Laura Navalta holds the prestigious position of Senior Vice President, Clinical Operations at Cidara Therapeutics. In this role, she leverages her extensive experience in clinical operations to oversee and direct the company's clinical trials team. Her leadership is critical in guiding the strategic and operational aspects of clinical development, ensuring that Cidara Therapeutics remains at the forefront of innovative therapeutic solutions.

Laura Navalta's Company

Laura Navalta is a key executive at Cidara Therapeutics, a biotechnology company focused on the discovery, development, and commercialization of novel anti-infectives and immunotherapies. Under her leadership, the clinical operations team conducts rigorous clinical trials to evaluate the safety and efficacy of new therapeutic agents. Cidara Therapeutics is committed to addressing unmet medical needs, particularly in the areas of infectious diseases and oncology, and Laura's role is pivotal in achieving these goals.

Laura Navalta's Experience

With over 30 years of experience in clinical operations, Laura Navalta has a distinguished career marked by significant leadership roles. Prior to her current position at Cidara Therapeutics, she served as Chief Operating Officer at C3 Jian Therapeutics and Novalar Pharmaceuticals, where she led clinical, regulatory, and project management functions. As Executive Director of Clinical Operations at Vical, Inc., she oversaw clinical trials in oncology and infectious disease programs. Her tenure as Senior Director of Global Clinical Operations at Baxter Healthcare Corporation involved managing global clinical studies in areas such as coagulation disorders, biosurgery, and critical care. Laura's extensive background in senior advisory roles across multiple therapeutic areas and phases of drug development underscores her expertise and dedication to advancing clinical research.

Laura Navalta's Education and Expertise

Laura Navalta earned a B.A. in Developmental Psychology from the University of Southern California, providing her with a strong foundation in understanding human behavior and development. This educational background complements her extensive expertise in clinical operations, as it enables her to approach clinical trials with a comprehensive perspective on patient care and treatment outcomes. Laura's deep knowledge and experience across various therapeutic areas and drug development phases make her a highly respected leader in the biotechnology and pharmaceutical industries.

Laura Navalta's Achievements

Throughout her illustrious career, Laura Navalta has achieved numerous milestones. As Chief Operating Officer at C3 Jian Therapeutics and Novalar Pharmaceuticals, she successfully led clinical, regulatory, and project management initiatives. At Vical, Inc., she played a crucial role in advancing clinical trials for oncology and infectious disease programs. During her tenure at Baxter Healthcare Corporation, she managed global clinical studies in critical medical areas such as coagulation disorders and biosurgery. Laura's ability to navigate complex clinical landscapes and her commitment to innovation have significantly contributed to the advancement of therapeutic solutions and improved patient outcomes.